Some may need to continue the medication long-term, while others may transition off it once theyve met their health goals. The future of GLP-1 medications Beyond weight loss and diabetes, GLP-1 medications are being studied for potential benefits in cardiovascular disease, kidney disease, neurodegenerative conditions and even alcohol use disorder
Numerous studies revealed that DM increases the risk of neurodegenerative diseases like Alzheimers and PD
Pre-existing GI Issues: Conditions that already slow down the gut may increase the likelihood of complications
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN
Maddah M, Karami L (2021) An atomistic investigation on the interaction of distamycin A and its derivative with the telomeric G-Quadruplex as anticancer agents by molecular dynamics simulation
Eur J Clin Nutr 2000, 54 Suppl 3: S131-42